Modulation of immunity by the secreted phospholipase A 2 family
Immunological Reviews · 2023-08 · 317 (1) · 42-70
DOI: 10.1111/imr.13205 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 10.04.2023. Verfasst von Makoto Murakami und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The …. Hauptthemen laut MEDLINE: Phospholipases A2, Secretory. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Among the phospholipase A 2 (PLA 2 ) superfamily, which typically catalyzes the sn ‐2 hydrolysis of phospholipids to yield fatty acids and lysophospholipids, the secreted PLA 2 (sPLA 2 ) family contains 11 isoforms in mammals. Individual sPLA 2 s have unique enzymatic specificity toward fatty acids and polar heads of phospholipid substrates and display distinct tissue/cellular distributions, suggesting their distinct physiological functions. Recent studies using knockout and/or transgenic mice for a full set of sPLA 2 s have revealed their roles in modulation of immunity and related disorders. Application of mass spectrometric lipidomics to these mice has enabled to identify target substrates and products of individual sPLA 2 s in given tissue microenvironments. sPLA 2 s hydrolyze not only phospholipids in the plasma membrane of activated, damaged or dying mammalian cells, but also extracellular phospholipids such as those in extracellular vesicles, microbe membranes, lipoproteins, surfactants, and dietary phospholipids, thereby exacerbating or ameliorating various diseases. The actions of sPLA 2 s are dependent on, or independent of, the generation of fatty acid‐ or lysophospholipid‐derived lipid mediators according to the pathophysiological contexts. In this review, we make an overview of our current understanding of the roles of individual sPLA 2 s in various immune responses and associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microenvironmental and Metabolic Health Science, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- AMED-CREST, Japan Agency for Medical Research and Development, Tokyo, Japan.
ORCID-Profile: Makoto Murakami
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Murakami, M., Sato, H., & Taketomi, Y. (2023). Modulation of immunity by the secreted phospholipase A 2 family. Immunological Reviews, 317(1), 42-70. https://doi.org/10.1111/imr.13205
Vancouver
Murakami M, Sato H, Taketomi Y. Modulation of immunity by the secreted phospholipase A 2 family. Immunological Reviews. 2023;317(1):42-70. doi:10.1111/imr.13205
BibTeX
@article{Murakami2023,
author = {Murakami, Makoto and Sato, Hiroyasu and Taketomi, Yoshitaka},
title = {Modulation of immunity by the secreted phospholipase A 2 family},
journal = {Immunological Reviews},
year = {2023},
volume = {317},
number = {1},
pages = {42--70},
doi = {10.1111/imr.13205}
}
EUVIMED